SOURCE: IBC Life Sciences

January 17, 2007 13:30 ET

IBC Announces FDA/CBER to Be a Featured Speaker at the 11th International Process Validation for Biologicals Conference

WESTBOROUGH, MA -- (MARKET WIRE) -- January 17, 2007 -- IBC is pleased to announce the confirmation of Chiang Syin, Ph.D., of FDA/CBER as a featured speaker at this year's 11th International Process Validation for Biologicals. Dr. Syin is the Chief of Manufacturing Review Branch I, Division of Manufacturing and Product Quality FDA/CBER and will present his update on current Process Validation issues from the FDA perspective on February 27, 2007.

In addition, on February 26, 2007 Dr. Anthony Mire-Sluis will present the keynote presentation "The Future for Process Validation - Is It All in the Name?" This presentation will explain how the use of Quality by Design, modular validation and platform technology can dramatically increase understanding and control of process variability to a point where repeating a process three to five times during validation may no longer be necessary. Jeffrey C. Baker, Ph.D., Senior Research Advisor, Manufacturing Science and Technology at Eli Lilly & Co will present a featured presentation, "The 'People Systems' in Validation Practices: Skills, Qualifications, and Suitability."

Also, on February 27, 2007 attendees will hear a unique and highly anticipated talk on linking Process Characterization to Process Validation presented by Anurag Rathore, Ph.D., Process Development Research Scientist, Amgen Inc.

This event is part of IBC's weeklong coverage of the latest approaches and solutions surrounding the development and manufacturing of biological and biopharmaceuticals at the La Costa Resort & Spa. Co-located with the Process Validation conference on February 26-27, 2007 are the Technology Transfer for Biopharmaceuticals and Outsourcing Manufacturing of Biopharmaceuticals conference. To end the week, IBC will hold its 18th International Antibody Development & Production conferences February 28-March 2, 2007.

Complete details can be found at

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit:

Contact Information

  • Contact:
    Dawn O'Connor
    IBC Life Sciences
    Email Contact